SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-22-242963
Filing Date
2022-09-12
Accepted
2022-09-12 17:00:00
Documents
12
Period of Report
2022-11-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A d375370dpre14a.htm PRE 14A 341185
2 GRAPHIC g375370g02a01.jpg GRAPHIC 48127
3 GRAPHIC g375370g04a08.jpg GRAPHIC 37031
4 GRAPHIC g375370g05k05.jpg GRAPHIC 151107
5 GRAPHIC g375370g11k89.jpg GRAPHIC 150050
6 GRAPHIC g375370g12a01.jpg GRAPHIC 25503
7 GRAPHIC g375370g12a02.jpg GRAPHIC 17057
8 GRAPHIC g375370g39a01.jpg GRAPHIC 62649
9 GRAPHIC g375370gra001.jpg GRAPHIC 3005
10 GRAPHIC g375370gra002.jpg GRAPHIC 3562
11 GRAPHIC g375370neilbelloff.jpg GRAPHIC 24209
12 GRAPHIC g375370roncohen.jpg GRAPHIC 19037
  Complete submission text file 0001193125-22-242963.txt   1077160
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31938 | Film No.: 221239126
SIC: 2836 Biological Products, (No Diagnostic Substances)